Octane, a Southern California innovation organization, will host its second annual Neuro Tech Forum on March 26–27, 2026, at the VEA Newport Beach. The two-day event is designed to bring together investors, physicians, and industry leaders to explore emerging opportunities in neurotechnology. According to the announcement, the forum will feature keynote speaker Nick Hopkins, panel discussions on digital health, brain-computer interfaces (BCI), neuromodulation, neurovascular innovation, and treatments for neurological and psychiatric disorders, as well as live pitches from six neuroscience and vascular startups. Emceed by Jojo Platt, the forum aims to connect innovative companies with Octane’s network of angel investors, venture capital firms, strategic partners, and medical leaders, while highlighting advances in areas such as endovascular therapies and wearable and implantable BCI technologies.
The event underscores the growing importance of neurotechnology in addressing neurological and psychiatric disorders, which affect millions worldwide. Brain-computer interfaces, in particular, have garnered significant attention in recent years for their potential to restore function in patients with paralysis, treat mental health conditions, and enhance cognitive abilities. Endovascular therapies, which involve minimally invasive procedures to treat conditions like stroke and aneurysms, are also advancing rapidly. By focusing on these cutting-edge areas, the Neuro Tech Forum aims to accelerate innovation and investment in a field that could transform healthcare.
Octane’s role as a connector in the Southern California innovation ecosystem is central to the event. The organization annually engages thousands of entrepreneurs, investors, and industry leaders through its forums, fostering growth within the tech and MedTech ecosystems. The Neuro Tech Forum specifically targets the neurotech sector, which spans medical devices, digital health, and neural engineering. Attendees will have the opportunity to hear from experts, network with potential partners, and evaluate investment opportunities in startups at the forefront of neurotechnology.
The inclusion of live pitches from six startups provides a platform for emerging companies to showcase their innovations to a targeted audience of investors and strategic partners. This format is intended to bridge the gap between breakthrough research and commercial viability, a critical step in bringing new treatments to patients. Previous Octane forums have facilitated connections that led to funding and collaborations, underscoring the organization’s impact on the regional innovation economy.
For more information about the Neuro Tech Forum, including registration details and the full agenda, interested parties can visit the full press release at https://ibn.fm/PMLoW. Octane’s broader initiatives and its role in supporting the tech and MedTech ecosystems are detailed on its website, while additional coverage of neurotechnology developments is available through InvestorWire, a platform that syndicates press releases and editorial content to a wide audience of investors and industry professionals.
